The rapid development of aHUS knowledge and its treatment in China
Until eight years ago China had no policy on the care of people with rare diseases. There were discussions about it…
Until eight years ago China had no policy on the care of people with rare diseases. There were discussions about it…
It kind of makes you think how can someone, who has a complement inhibitor treatment that blocks their C5 from being…
Hope Emerges for India's aHUS Patients After Years of Struggle After years of waiting in the shadows of India's healthcare system,…
The annual aHUS Awareness Day video ( see HERE) had a theme of best decision making in the recovery from an…
What is it like from an aHUS patients' perspective to decide to withdraw from complement inhibitor treatment? Much is published about…
Raising aHUS awareness is built into the DNA of the aHUS alliance and has been from its outset and also for…
Hiding in plain sight were neighbours Republic of Ireland and Iceland. The south of Ireland is well known as the place…
It is said that thrombomodulin, or TM (AKA THBD) ,or CD141, plays only an indirect part in TMA (thrombotic microangiopathy) .…
The drug Epysqli or the version of eculizumab known as eculizumab-aagh has been available in some countries since 2024 . Although…